Global Intellectual Property Center

Enforcement

Count out Counterfeits this Holiday Season: GIPC’s Top Ten Tips to #ShopSafe

Count out Counterfeits this Holiday Season: GIPC’s Top Ten Tips to #ShopSafe

Thanksgiving weekend isn’t just about stuffing the turkey – more and more Americans are using Thanksgiving weekend as an excuse to stuff their stockings and get an early start to their holiday shopping. Many Americans will find the perfect gift, but some will end up with more than they bargained for: dangerous counterfeit goods. Counterfeit […]

The Intersection of Trademarks and Brands: A Dialogue with Famous Brands and Law Enforcement

The Intersection of Trademarks and Brands: A Dialogue with Famous Brands and Law Enforcement

In today’s fast-paced, evolving retail environment, consumers are faced with more purchasing decisions than ever before. The questions of what to buy and where to buy it have nearly infinite answers. Fortunately, consumers can rely on trademarks as a trusted identifier in the marketplace. And considering the work happening at the Congressional Trademark Caucus, consumers […]

U.S. Chamber Applauds Approval of White House Intellectual Property Advisor

U.S. Chamber Applauds Approval of White House Intellectual Property Advisor

WASHINGTON, D.C. — U.S. Chamber President and CEO of the Global Intellectual Property Center David Hirschmann today applauded Senate approval of Vishal J. Amin, President Trump’s nominee for White House Intellectual Property Enforcement Coordinator (IPEC): “The Chamber looks forward to working with Mr. Amin to ensure strong enforcement of our trade agreements; increased protections against illicit […]

U.S. Chamber Applauds Supreme Court Ruling on Canada’s “Promise Doctrine”

U.S. Chamber Applauds Supreme Court Ruling on Canada’s “Promise Doctrine”

WASHINGTON, D.C. — The U.S. Chamber of Commerce’s Global Intellectual Property Center (GIPC) issued the following statement in response to today’s Supreme Court of Canada ruling in AstraZeneca Canada Inc. v. Apotex Inc. The Court ruled in favor of  innovative drug company AstraZeneca and rejected use of Canada’s controversial “Promise Doctrine” policy to overturn patents. “We welcome today’s ruling that […]